AMBU B Stock Overview
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.109.80 |
| 52 Week High | kr.121.65 |
| 52 Week Low | kr.61.26 |
| Beta | 0.57 |
| 1 Month Change | 6.50% |
| 3 Month Change | 7.02% |
| 1 Year Change | 24.43% |
| 3 Year Change | -50.96% |
| 5 Year Change | -41.84% |
| Change since IPO | 6,311.68% |
Recent News & Updates
Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet
May 07
Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Mar 24Recent updates
Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet
May 07Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture
Mar 24We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Jan 20Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Dec 08Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?
Sep 23Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends
Sep 08We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt
Aug 21Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital
Jun 06These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively
May 19Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Jan 23Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?
Dec 12Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?
Oct 04Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around
Jul 20Here's Why Ambu (CPH:AMBU B) Can Manage Its Debt Responsibly
May 14Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?
Apr 19Shareholders Are Raving About How The Ambu (CPH:AMBU B) Share Price Increased 471%
Feb 25Results: Ambu A/S Beat Earnings Expectations And Analysts Now Have New Forecasts
Jan 30A Look At The Fair Value Of Ambu A/S (CPH:AMBU B)
Jan 17Here's Why Ambu (CPH:AMBU B) Can Manage Its Debt Responsibly
Dec 19What Percentage Of Ambu A/S (CPH:AMBU B) Shares Do Insiders Own?
Nov 30
Calculating The Fair Value Of Ambu A/S (CPH:AMBU B)
Jul 07Shareholder Returns
| AMBU B | DK Medical Equipment | DK Market | |
|---|---|---|---|
| 7D | -2.0% | -3.3% | -1.2% |
| 1Y | 24.4% | 7.0% | 20.0% |
Return vs Industry: AMBU B exceeded the Danish Medical Equipment industry which returned 6% over the past year.
Return vs Market: AMBU B exceeded the Danish Market which returned 18.9% over the past year.
Price Volatility
| AMBU B volatility | |
|---|---|
| AMBU B Average Weekly Movement | 6.1% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DK Market | 9.6% |
| 10% least volatile stocks in DK Market | 3.0% |
Stable Share Price: AMBU B is not significantly more volatile than the rest of Danish stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: AMBU B's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 4,500 | Britt Jensen | https://www.ambu.com |
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| AMBU B fundamental statistics | |
|---|---|
| Market Cap | kr.29.21b |
| Earnings (TTM) | -kr.65.00m |
| Revenue (TTM) | kr.4.61b |
6.3x
P/S Ratio-449.4x
P/E RatioIs AMBU B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMBU B income statement (TTM) | |
|---|---|
| Revenue | kr.4.61b |
| Cost of Revenue | kr.2.01b |
| Gross Profit | kr.2.60b |
| Other Expenses | kr.2.66b |
| Earnings | -kr.65.00m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Aug 31, 2023
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 56.35% |
| Net Profit Margin | -1.41% |
| Debt/Equity Ratio | 6.5% |
How did AMBU B perform over the long term?
See historical performance and comparison